XASX
IRI
Market cap36mUSD
Oct 09, Last price
0.28AUD
1D
-3.45%
1Q
3.70%
Jan 2017
-90.00%
IPO
-82.50%
Name
Integrated Research Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Integrated Research Limited (IRI.AX), an Australian company founded in North Sydney in 1988, specializes in developing, deploying, and selling computer software for managing critical IT systems. Their solutions address business-critical computing, unified communication, and payment networks. The company's flagship product, Prognosis, is a comprehensive software suite engineered to provide management and technical teams with detailed operational insight into platforms such as HP NonStop, distributed system servers, unified communications environments, payment infrastructures, and core business applications. Beyond software, they also deliver testing, maintenance, and professional services, including a Software-as-a-Service (SaaS) option. Integrated Research operates globally, reaching clients in approximately 60 countries through direct sales offices in the United States, the United Kingdom, Germany, Singapore, and Australia, complemented by a broad international channel-driven distribution network. Their diverse customer base includes financial institutions like stock exchanges, banks, and credit card companies, alongside telecommunications carriers, service providers, and manufacturers.
Key people
Peter Lloyd
Independent Non-Executive Chairman of the Board · since 2021
Christian Shaw
Chief Financial Officer · since 2024
William Witherow
General Counsel · since 2024
Ian Lowe
Chief Executive Officer, Managing Director · since 2024
Leanne Ralph
Company Secretary · since 2024
Non-Executive Independent Director · since 2023
Non-Executive Independent Director · since 2024
Michael Hitz
Non-Executive Independent Director · since 2023
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||